Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Sun Pharma buys fellow Indian generics competitor Ranbaxy for Rs194bn, plus assumption of debt

Executive Summary

In a move to create India’s largest pharmaceutical company, which would hold a 9.2% share of the generics market there, Sun Pharmaceutical Industries Ltd. acquired fellow Indian generics player and competitor Ranbaxy Laboratories Ltd. (branded generics, OTC products, and active pharmaceutical ingredients (APIs)).

Deal Industry
  • Pharmaceuticals
  • Services
  • Pharmaceuticals
    • Generic Drugs
    • Nutraceuticals
    • OTC, Consumer
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Payment Includes Stock

Related Companies